Bevacizumab: An Immune Therapy in Mesothelioma Treatment
Bevacizumab, an immune therapy, enhances the immune system to target cancer cells. Historically, chemotherapy drugs were considered the standard treatment.…
Emerging treatments & clinical trials based on how immune systems affect the development of mesothelioma cell types. Get up to date analysis.